Key Milestones

MEDICAMEN Biotech has constantly strived to be on the path of growth on the strength of its brilliant human resource, world class facilities and a global vision of its Management.

From being a purely Formulation manufacturer of general products, the Company has diversified into setting up a state-of-the-art R&D Centre followed by a most modern API manufacturing facility and, lastly, setting up a highly auditable facility for manufacturing Oncology injectables and OSDs which will stand the test of leading global regulatory agencies. Please find below our journey from humble beginnings to being a vertically integrated Group:

Chronology of Events

  • Achievements
  • 1993
    Medicamen established.
  • 1995
    IPO issued – BSE listed.
  • 1996
    Operations started - Bhiwadi FDF Plant
  • 1998
    WHO-GMP Received – Bhiwadi FDF Plant
  • 2000
    ISO certification – Bhiwadi FDF Plant
  • Achievements
  • 2001: Global Accreditation
    NDA(Uganda), ANVISA(Brazil),FM HACA( Ethiopia)-Bhiwadi FDF Plant
  • 2007
    Operations started – Haridwar Unit-I (FDF)
  • Achievements
  • 2018
    New R&D center setup along with Upgradation & Mordernization of Bhiwadi FDF plant
  • 2016
    Shivalik Rasayan Ltd take controlling stake of Medicamen Biotech Ltd
  • 2019: Global Accreditation
    FABD(Philippines), CECMED(Cuba)-Bhiwadi FDF Plant
  • 2020
    Global API Facility started– Dahej API Plant
  • Achievements
  • 2021
    Operations started: Haridwar formulation Unit –II(FDF) (oncology)
  • 2021
    Filing API USDMFs & CEPs